Neuropathological Interactions Between COVID-19 and ADRD (R01 – Clinical Trial Not Allowed)
Deadline: September 04, 2023
The goal of this initiative is to solicit applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates ADRD-relevant mechanisms and outcomes. Either the model itself or the experimental readouts must incorporate ADRD risk factors, causes, pathologies, or relevant comorbidities.
For more information, please see the funding announcement website.